Picture of SenzaGen AB logo

SENZA SenzaGen AB Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Annual cashflow statement for SenzaGen AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-31.3-24.9-22.1-17.9-11.6
Depreciation
Deferred Taxes
Non-Cash Items0.0060.225-0.1782.797.56
Unusual Items
Other Non-Cash Items
Changes in Working Capital6.09-0.797-5.77-5.65-2.76
Change in Accounts Receivable
Change in Inventories
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-21-16.1-16.5-9.33-6.82
Capital Expenditures-0.331-0.607-0.129-0.656-3.01
Purchase of Fixed Assets
Other Investing Cash Flow Items-26.2-12.8-5.95-3.59-2.44
Acquisition of Business
Sale of Business
Change in Net Investments
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities-26.6-13.4-6.08-4.25-5.45
Financing Cash Flow Items-2.31-0.0420-2.65-0.811
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities27.30.0310.14735.5-0.388
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-20.2-29.2-22.422-12.8